Progress and remaining challenges for cancer control in Latin America and the Caribbean

About us
- Our story
- Leaders and team
Research Groups
- Breast
- Digital
- Gastrointestinal
- Genitourinary
- Geriatric
- Gynecological
- Head and Neck
- Lung
- Neuro
- Radiation
- Sarcoma
Studies
- Clinical Trials
  - Ongoing
  - Closed
- Epidemiological Studies
  - Ongoing
  - Closed
Publications
Events
- LACOG Events
- Next events
News

About us
- Our story
- Leaders and team
Research Groups
- Breast
- Digital
- Gastrointestinal
- Genitourinary
- Geriatric
- Gynecological
- Head and Neck
- Lung
- Neuro
- Radiation
- Sarcoma
Studies
- Clinical Trials
  - Ongoing
  - Closed
- Epidemiological Studies
  - Ongoing
  - Closed
Publications
Events
- LACOG Events
- Next events
News

01/10/2015

Articles, Publications

Martínez-Mesa J, Werutsky G, Campani RB, Wehrmeister FC, Barrios CH.
Prev Med. 2013 Oct;57(4):366-71

Full link: https://www.thelancet.com/commissions/latin-america

17/11/2015

Exploiting HPV-induced carcinogenesis for a rational drug development in cervical cancer.

04/11/2015

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

09/08/2015

Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil

10/06/2015

The Global Conduct of Cancer Clinical Trials: Challenges and Opportunities

Search

More results...

Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Publications by year

2010 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

LACOG Office

Tecnopuc | Av. Ipiranga, nº 6681
Prédio 99A - Sala 1401
Porto Alegre - RS - Brazil
Phone: +55 (51) 3384.5334
Opening Hours: 8:00 am to 5:00 pm

List of public holidays

lacog@lacog.org.br

Send us a message

Cura Project

The project

Progress and remaining challenges for cancer control in Latin America and the Caribbean

Related Posts

Exploiting HPV-induced carcinogenesis for a rational drug development in cervical cancer.

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil

The Global Conduct of Cancer Clinical Trials: Challenges and Opportunities